206 related articles for article (PubMed ID: 10504484)
1. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
[TBL] [Abstract][Full Text] [Related]
2. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.
Matsunaga A; Sasaki J; Komatsu T; Kanatsu K; Tsuji E; Moriyama K; Koga T; Arakawa K; Oikawa S; Saito T; Kita T; Doi T
Kidney Int; 1999 Aug; 56(2):421-7. PubMed ID: 10432380
[TBL] [Abstract][Full Text] [Related]
3. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy.
Konishi K; Saruta T; Kuramochi S; Oikawa S; Saito T; Han H; Matsunaga A; Sasaki J
Nephron; 1999; 83(3):214-8. PubMed ID: 10529627
[TBL] [Abstract][Full Text] [Related]
4. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
5. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].
Han HL; Lin S; Sun LS; Zhang P; Zhai DP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820
[TBL] [Abstract][Full Text] [Related]
6. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
[TBL] [Abstract][Full Text] [Related]
7. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].
Chen YQ; Zhang H; Zhu SL; Zou WZ; Wang M; Liu ZS; Wang HY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):774-7. PubMed ID: 12899757
[TBL] [Abstract][Full Text] [Related]
8. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report.
Xie W; Xie Y; Lin Z; Xu X; Zhang Y
Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy.
Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J
J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
Biochim Biophys Acta; 1992 Sep; 1128(1):58-64. PubMed ID: 1356443
[TBL] [Abstract][Full Text] [Related]
11. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia.
Miller DB; Hegele RA; Wolfe BM; Huff MW
J Clin Endocrinol Metab; 1995 Mar; 80(3):807-13. PubMed ID: 7883834
[TBL] [Abstract][Full Text] [Related]
12. A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).
Kobayashi J; Shirai K; Murano T; Misawa Y; Tashiro J; Yoshida T; Shinomiya M
Biochim Biophys Acta; 2002 Jun; 1583(1):117-21. PubMed ID: 12069856
[TBL] [Abstract][Full Text] [Related]
13. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
Sakuma N; Hibino T; Saeki T; Nagata T; Sato T; Okuda N; Matsunaga A; Sasaki J
J Atheroscler Thromb; 2014; 21(9):983-8. PubMed ID: 24953047
[TBL] [Abstract][Full Text] [Related]
14. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
[TBL] [Abstract][Full Text] [Related]
16. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia.
Hsia SH; Connelly PW; Hegele RA
J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921
[TBL] [Abstract][Full Text] [Related]
17. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
[TBL] [Abstract][Full Text] [Related]
19. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.
Chen S; Liu ZH; Zheng JM; Zhang X; Li LS
J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing.
Kontula K; Aalto-Setälä K; Kuusi T; Hämäläinen L; Syvänen AC
Clin Chem; 1990 Dec; 36(12):2087-92. PubMed ID: 2253351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
